Detalles de la búsqueda
1.
Modeling predictors of latent classes in regression mixture models.
Struct Equ Modeling
; 23(4): 601-614, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-31588168
2.
Apixaban following discharge in hospitalised adults with COVID-19: Preliminary results from a multicentre, open-label, randomised controlled platform clinical trial.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22283175
3.
Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20137273
4.
Prophylactic Treatment of COVID-19 in Care Homes Trial (PROTECT-CH)
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22279359
5.
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22280285
6.
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21258542
7.
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21258132
8.
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21257267
9.
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20245944
10.
A Randomised -Controlled Phase 2 trial of Molnupiravir in Unvaccinated and Vaccinated Individuals with Early SARS-CoV-2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22277797
11.
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20151852
12.
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22271623
13.
An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS-CoV-2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21263376
14.
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a phase 1, dose-escalating, randomised controlled study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21256309
15.
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21249258
16.
Higher dose corticosteroids in hospitalised COVID-19 patients with hypoxia but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22283578
17.
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21252736
Resultados
1 -
17
de 17
1
Próxima >
>>